Skip to main content
PMC home page
Age logoLink to Age
. 2005 May 2;27(1):39–48. doi: 10.1007/s11357-005-3284-4

Caloric restriction versus drug therapy to delay the onset of aging diseases and extend life

Arthur V Everitt 1,2, George S Roth 3,✉, David G Le Couteur 1, Sarah N Hilmer 1
PMCID: PMC3456093  PMID: 23598602

Abstract

There are two firmly established methods of prolonging life. Calorie restriction (CR) using nutrient-rich diets to prolong life in lower animals, and life saving medications in humans to delay the development of the major diseases of middle and old age. These two approaches have different mechanisms of action. In rats, CR at 40% below ad libitum intake begun soon after weaning and continued until death, reduces body weight by about 40% and increases lifespan. There have been no lifelong CR studies performed on humans. However, in healthy adult human subjects about 20% CR over a period of 2–15 years, lowers body weight by about 20% and decreases body mass index (BMI) to about 19. This CR treatment in humans reduces blood pressure and blood cholesterol to a similar extent as the specific drugs used to delay the onset of vascular disease and so extend human life. These same drugs may act by mechanisms that overlap with some of the mechanisms of CR in retarding these pathologies and thus may have similar antiaging and life prolonging actions. Such drugs may be regarded as CR mimetics which inhibit the development of certain life shortening diseases, without the need to lower calorie intake. In developed countries, better medical care, drug therapy, vaccinations, and other public health measures have extended human life by about 30 years during the 20th century without recourse to CR, which is so effective in the rat. The percentage gain in human life expectancy during the 20th century is twice that achieved by CR in rat survival. However, rat longevity studies now use specific pathogen-free animals and start CR after weaning or later, thereby excluding deaths from infectious diseases and those associated with birth and early life. There is a need to develop CR mimetics which can delay the development of life-threatening diseases in humans. In the 21st century due to the human epidemic of overeating with a sedentary lifestyle, it may necessary to utilize CR to counter the aging effects of overweight. Since the greatest life-extending effects of CR in the rodent occur when started early in life, long-term antiaging therapy in humans should be initiated soon after maturity, when physiological systems have developed optimally.

Key words: blood pressure, calorie restriction mimetics, cardiovascular disease, cholesterol, lifespan, medications

Full Text

The Full Text of this article is available as a PDF (215.2 KB).

References

  1. Anisimov VN. Effects of exogenous melatonin – a review. Toxicol Pathol. 2003;31:589–603. doi: 10.1080/01926230390257885. [DOI] [PubMed] [Google Scholar]
  2. Anisimov VN. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Exp Gerontol. 2003;38:1041–1049. doi: 10.1016/S0531-5565(03)00169-4. [DOI] [PubMed] [Google Scholar]
  3. Anisimov VN, Semenchenko AV, Yashin AI. Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology. 2003;4:297–307. doi: 10.1023/A:1026299318315. [DOI] [PubMed] [Google Scholar]
  4. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV, Yashin AI. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4:193–200. doi: 10.1023/A:1025114230714. [DOI] [PubMed] [Google Scholar]
  5. Barbieri M, Bonafe M, Franceschi C, Paolisso G. Insulin/IGF-1-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol: Endocrinol Metab. 2003;285:E1064–E1071. doi: 10.1152/ajpendo.00296.2003. [DOI] [PubMed] [Google Scholar]
  6. Barrows CH, Jr, Kokkonen GC. Dietary restriction and life extension – biological mechanisms. In: Moment GB, editor. Nutritional Approaches to Aging Research. Boca Raton, FL: CRC Press; 1982. pp. 219–243. [Google Scholar]
  7. Bartke A, Coschigano K, Kopchick J, Chandrashekkar V, Mattson J, Kinney B, Hauck S. Genes that prolong life: relationships of growth hormone and growth to aging and lifespan. J Gerontol. 2001;56:B340–B349. doi: 10.1093/gerona/56.8.b340. [DOI] [PubMed] [Google Scholar]
  8. Berg BN, Simms HS. Nutrition, onset of disease, and longevity in the rat. Can Med Assoc J. 1965;93:911–913. [PMC free article] [PubMed] [Google Scholar]
  9. Bernarducci MP, Owens NJ. Is there a fountain of youth? A review of current life extension strategies. Pharmacotherapy. 1996;16:183–200. [PubMed] [Google Scholar]
  10. Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E, Hansen BC. Mortality and morbidity in laboratory maintained Rhesus monkeys and effects of long-term dietary restriction. J Gerontol Biol Sci. 2003;58A:212–221. doi: 10.1093/gerona/58.3.b212. [DOI] [PubMed] [Google Scholar]
  11. Brand-Miller JC, Holt SHA, Pawlak DB, McMillan J. Glycemic index and obesity. Am J Clin Nutr. 2002;76(Suppl):281S–285S. doi: 10.1093/ajcn/76/1.281S. [DOI] [PubMed] [Google Scholar]
  12. Broe GA, Creasey H. Brain ageing and neurodegenerative diseases: a major public health issue of the 21st century. Perspect Hum Biol. 1995;1:53–58. [Google Scholar]
  13. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, Dalton M, Jolley D, Shaw JE. Overweight and obesity in Australia: the 1999–2000 Australian diabetes, obesity and lifestyle study (AusDiab) Med J Aust. 2003;178:427–432. doi: 10.5694/j.1326-5377.2004.tb05998.x. [DOI] [PubMed] [Google Scholar]
  14. Carter CS, Ramsey MM, Ingram RL, Cashion AB, Cefalu WT, Wang ZQ, Sonntag WE. Models of growth hormone and IGF-1 deficiency: application to studies of aging processes and life-span determination. J Gerontol. 2002;57:B177–B188. doi: 10.1093/gerona/57.5.b177. [DOI] [PubMed] [Google Scholar]
  15. Cooper MR, Stewart DC, Kahl FR, Brown WM, Cordell AR. Medicine at the medical center then and now: one hundred years of progress. South Med J. 2002;95:1113–1121. [PubMed] [Google Scholar]
  16. Dhahbi JM, Kim H-J, Mote PL, Beaver RJ, Spindler SR. Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci USA. 2004;101:5524–5529. doi: 10.1073/pnas.0305300101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;348:393–403. doi: 10.1056/NEJMoa012512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Buono M, Hannah JS, Katzel LI, Jones PJ. Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J Nutr. 1999;129:1545–1548. doi: 10.1093/jn/129.8.1545. [DOI] [PubMed] [Google Scholar]
  19. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;326:1519–1528. doi: 10.1136/bmj.38142.554479.AE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC. Dietary restriction reduces insulin-like growth factor 1 levels, which modulates apoptosis, cell proliferation, and tumor progression in p53 deficient mice. Cancer Res. 1997;57:4667–4672. [PubMed] [Google Scholar]
  21. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luff F, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45:356–362. doi: 10.1161/01.HYP.0000154361.47683.d3. [DOI] [PubMed] [Google Scholar]
  22. Everitt AV. Food restriction, pituitary hormones and ageing. Biogerontology. 2003;4:47–50. doi: 10.1023/a:1022439701606. [DOI] [PubMed] [Google Scholar]
  23. Everitt AV. Can calorie restriction prolong life? Med Today. 2004;5:91–92. [Google Scholar]
  24. Everitt AV, Cavanagh LM. The effect of chronic lung disease on the course of ageing in the male rat. Gerontologia. 1963;8:1–15. doi: 10.1159/000211214. [DOI] [PubMed] [Google Scholar]
  25. Ferruci L, Izmirlian G, Leveille S, Phillips CL, Corti MC, Brock DB, Guralnik JM. Smoking, physical activity, and active life expectancy. Am J Epidemiol. 1999;149:645–653. doi: 10.1093/oxfordjournals.aje.a009865. [DOI] [PubMed] [Google Scholar]
  26. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187–193. doi: 10.1001/jama.289.2.187. [DOI] [PubMed] [Google Scholar]
  27. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term caloric restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA. 2004;101:6659–6663. doi: 10.1073/pnas.0308291101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Fraser GE, Shavlik DJ. Ten years of life: is it a matter of choice? Arch Intern Med. 2001;161:1645–1652. doi: 10.1001/archinte.161.13.1645. [DOI] [PubMed] [Google Scholar]
  29. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes Res. 2002;10(Suppl 2):116S–123S. doi: 10.1038/oby.2002.204. [DOI] [PubMed] [Google Scholar]
  30. Guyer B, Freedman MA, Strobino DM, Sondik EJ. Annual summary of vital statistics: trends in the health of Americans during the 20th century. Pediatrics. 2000;106:1307–1317. doi: 10.1542/peds.106.6.1307. [DOI] [PubMed] [Google Scholar]
  31. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll IT, Vinarsky V, Bartholomew C, Ames BN. Feeding acetyl-l-carnitine and lipoic acid to old rats significantly improves metabolic function, while decreasing oxidative stress. Proc Natl Acad Sci USA. 2002;123(425):191–196. doi: 10.1073/pnas.261708898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hansen BC, Bodkin NL. Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes. 1993;42:1809–1814. doi: 10.2337/diab.42.12.1809. [DOI] [PubMed] [Google Scholar]
  33. Heilbronn LK, Ravussen E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr. 2003;78:361–369. doi: 10.1093/ajcn/78.3.361. [DOI] [PubMed] [Google Scholar]
  34. Hipkiss AR, Brownson C, Carrier MJ. Carnosine the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech Ageing Dev. 2001;122:1431–1435. doi: 10.1016/s0047-6374(01)00272-x. [DOI] [PubMed] [Google Scholar]
  35. Holloszy JO. Mortality rate and longevity of food-restricted exercising male rats: a reevaluation. J Appl Physiol. 1997;82:399–403. doi: 10.1152/jappl.1997.82.2.399. [DOI] [PubMed] [Google Scholar]
  36. Howitz KI, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielwski A, Zhang JJ, Scherer H, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191–196. doi: 10.1038/nature01960. [DOI] [PubMed] [Google Scholar]
  37. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med. 2003;54:131–152. doi: 10.1146/annurev.med.54.101601.152156. [DOI] [PubMed] [Google Scholar]
  38. Ingram DK, Cutler RG, Weindruch R, Renquist DM, Knapka JM, April M, Belcher CT, Clark MA, Hatcherson CD, Marriott BM, Roth GS. Dietary restriction and aging: the initiation of a primate study. J Gerontol Biol Sci. 1990;48:B148–B163. doi: 10.1093/geronj/45.5.b148. [DOI] [PubMed] [Google Scholar]
  39. Ingram DK, Ansom RM, Caro R, Mamczarz J, Zhu M, Mattison J, Lane MA, Roth G. Development of calorie restriction mimetics as a prolongevity strategy. Ann NY Acad Sci. 2004;1019:412–423. doi: 10.1196/annals.1297.074. [DOI] [PubMed] [Google Scholar]
  40. Janssens H. Endocrine aspects of ageing in men. Is hormone replacement of benefit? Eur J Obstet Gynecol Reprod Biol. 2000;92:7–12. doi: 10.1016/S0301-2115(00)00420-6. [DOI] [PubMed] [Google Scholar]
  41. Kannel WB, Thom TJ. Declining cardiovascular mortality. Circulation. 1984;70:331–336. doi: 10.1161/01.cir.70.3.331. [DOI] [PubMed] [Google Scholar]
  42. Keenan KP, Smith PF, Soper KA. Effect of dietary (caloric) restriction on aging, survival, pathology, and toxicology, in pathobiology of the aging rat. Int Life Sci Inst. 1994;2:609–628. [Google Scholar]
  43. Kitani K, Minami C, Yamamoto T, Kanai S, Ivy GO, Carrillo MC. Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use. Ann NY Acad Sci. 2000;959:295–307. doi: 10.1111/j.1749-6632.2002.tb02101.x. [DOI] [PubMed] [Google Scholar]
  44. Lane MA, Ball SS, Ingram DK, Cutler RG, Engel J, Read V, Roth GS. Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory endpoints. Am J Physiol. 1995;268:E941–E948. doi: 10.1152/ajpendo.1995.268.5.E941. [DOI] [PubMed] [Google Scholar]
  45. Lane MA, Ingram DK, Roth GS. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular risk. Toxicol Sci. 1999;52(2 Suppl):41–48. doi: 10.1093/toxsci/52.2.41. [DOI] [PubMed] [Google Scholar]
  46. Lane MA, Tilmont EM, DeAngelis H, Handy AM, Ingram DK, Kemnitz JW, Baum ST, Roth GS. Short-term calorie restriction improves disease related markers in older male rhesus monkeys (Macaca mulatta) Mech Ageing Dev. 2000;112:185–196. doi: 10.1016/S0047-6374(99)00087-1. [DOI] [PubMed] [Google Scholar]
  47. Lane MA, Mattison J, Ingram DK, Roth GS. Caloric restriction and aging in primates: elevance to humans and possible CR mimetics. Microsc Res Tech. 2002;59:335–338. doi: 10.1002/jemt.10214. [DOI] [PubMed] [Google Scholar]
  48. Lane MA, Mattison JA, Roth GS, Brandt LJ, Ingram DK. Effects of long-term diet restriction on aging and longevity in primates remains uncertain. J Gerontol Biol Sci. 2004;59A:405–407. doi: 10.1093/gerona/59.5.b405. [DOI] [PubMed] [Google Scholar]
  49. Law MR, Wald NJ, Rudnicka AR. Quantifying effects of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326:1423–1427. doi: 10.1136/bmj.326.7404.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427–1431. doi: 10.1136/bmj.326.7404.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet. 2002;359:1612–1615. doi: 10.1016/S0140-6736(02)08524-0. [DOI] [PubMed] [Google Scholar]
  52. Couteur DG, Muller M, Yang M, Mellick GD, McLean AJ. Age–environment and gene–environment interactions in the pathogenesis of Parkinson’s disease. Rev Environ Health. 2002;17:51–64. doi: 10.1515/reveh.2002.17.1.51. [DOI] [PubMed] [Google Scholar]
  53. Couteur DG, Fraser R, Hilmer SN, Rivory LP, McLean AJ. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet. 2005;44:187–200. doi: 10.2165/00003088-200544020-00004. [DOI] [PubMed] [Google Scholar]
  54. Linnane AW, Zhang C, Yarovaya N, Kopsidas G, Kovalenko S, Papakostopoulos P, Eastwood H, Graves S, Richardson M. Human aging and global function of coenzyme Q10. Ann NY Acad Sci. 2002;959:396–411. doi: 10.1111/j.1749-6632.2002.tb02110.x. [DOI] [PubMed] [Google Scholar]
  55. Lipman RD, Dallah GE, Bronson RT. Lesion biomarkers of aging in B6C3F1 hybrid mice. J Gerontol. 1999;54A:B466–B477. doi: 10.1093/gerona/54.11.b466. [DOI] [PubMed] [Google Scholar]
  56. Longo VD, Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science. 2003;299:1342–1346. doi: 10.1126/science.1077991. [DOI] [PubMed] [Google Scholar]
  57. Masoro EJ. Dietary restriction. Exp Gerontol. 1995;30:291–298. doi: 10.1016/0531-5565(94)00028-2. [DOI] [PubMed] [Google Scholar]
  58. Masoro EJ. Caloric Restriction: a Key to Understanding and Modulating Aging. Amsterdam: Elsevier; 2002. [Google Scholar]
  59. Masoro ET. Mortality characteristics. In: Masoro ET, editor. Caloric Restriction: a Key to Understanding and Modulating Aging. Amsterdam: Elsevier; 2002. pp. 165–178. [Google Scholar]
  60. Masoro ET. Caloric restriction mimetics. Chapter. In: Masoro ET, editor. Caloric Restriction: a Key to Understanding and Modulating Aging. Amsterdam: Elsevier; 2002. pp. 165–178. [Google Scholar]
  61. Masoro EJ, McCarter RJM, Katz MS, McMahon CA. Dietary restriction alters characteristics of glucose fuel use. J Gerontol. 1992;47:B202–B208. doi: 10.1093/geronj/47.6.b202. [DOI] [PubMed] [Google Scholar]
  62. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of the lifespan and ultimate body size. J Nutr. 1935;10:63–79. [PubMed] [Google Scholar]
  63. McCormack J. Hitting a century: centenarians in Australia. Aust J Ageing. 2000;19:75–80. [Google Scholar]
  64. McGinnis M, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207–2212. doi: 10.1001/jama.270.18.2207. [DOI] [PubMed] [Google Scholar]
  65. McLean A, Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56:163–184. doi: 10.1124/pr.56.2.4. [DOI] [PubMed] [Google Scholar]
  66. Miller RD, Jr, Frech HE. Is there a link between pharmaceutical consumption and improved health in OECD countries? Pharmacoeconomics. 2000;18(Suppl 1):33–45. doi: 10.2165/00019053-200018001-00006. [DOI] [PubMed] [Google Scholar]
  67. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1263–1264. doi: 10.1001/jama.291.10.1263. [DOI] [PubMed] [Google Scholar]
  68. Morley JE. Growth hormone: fountain of youth or death hormone? J Am Geriat Soc. 1999;47:1475–1476. doi: 10.1111/j.1532-5415.1999.tb01572.x. [DOI] [PubMed] [Google Scholar]
  69. Morley JE. Diabetes mellitus: a major disease of older persons. J Gerontol Med Sci. 2000;55A:M255–M256. doi: 10.1093/gerona/55.5.m255. [DOI] [PubMed] [Google Scholar]
  70. Morley JE. Is the hormonal fountain of youth drying up? J Gerontol Med Sci. 2004;59A:458–460. doi: 10.1093/gerona/59.5.m458. [DOI] [PubMed] [Google Scholar]
  71. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529. doi: 10.1001/jama.282.16.1523. [DOI] [PubMed] [Google Scholar]
  72. National Vital Statistics Reports (2004) Center for Disease Control and Prevention, Vol 52, # 13. Natl Ctr Health Stats, Hyattsville, MD
  73. Nawata H, Yanese T, Goto K, Okabe T, Ashida K. Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech Ageing Dev. 2002;123:1101–1106. doi: 10.1016/S0047-6374(01)00393-1. [DOI] [PubMed] [Google Scholar]
  74. Tiffen R, Gittens R, editors. How Australia Compares. Cambridge, UK: Cambridge University Press; 2004. pp. 210–211. [Google Scholar]
  75. Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538–545. doi: 10.1056/NEJM199302253280804. [DOI] [PubMed] [Google Scholar]
  76. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xian XG, Cao HB, Liu PA, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544. doi: 10.2337/diacare.20.4.537. [DOI] [PubMed] [Google Scholar]
  77. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Mamum A, Bonneux L, NEDCOM, The Netherlands Epidemiology and Demography Comparison of Morbidity Research Group Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24–32. doi: 10.7326/0003-4819-138-1-200301070-00008. [DOI] [PubMed] [Google Scholar]
  78. Percheron G, Hogrel JY, Donot-Ledunois S, Fayet G, Foret G, Baulieu EE, Fardeau M, Marini JF. Effect of 1-year oral administration of dehydroepi-androsterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double blind placebo-controlled trial. Arch Intern Med. 2003;163:720–727. doi: 10.1001/archinte.163.6.720. [DOI] [PubMed] [Google Scholar]
  79. Phillips PJ, Popplewell P, Wing L. Diabetes and hypertension — double trouble. Med Today. 2003;4:32–46. [Google Scholar]
  80. Reaven GH. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473–485. doi: 10.1152/physrev.1995.75.3.473. [DOI] [PubMed] [Google Scholar]
  81. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346–1353. doi: 10.1016/S0140-6736(04)16044-3. [DOI] [PubMed] [Google Scholar]
  82. Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2003;57:121–126. doi: 10.1046/j.1365-2125.2003.01875.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Savo A, Maiorano PM, Onder G, Bernabei R. Pharmacoepidemiology and disability in older adults: can medications slow the age-related decline in physical functions? Expert Opin Pharmacother. 2003;5:407–413. doi: 10.1517/eoph.5.2.407.26467. [DOI] [PubMed] [Google Scholar]
  84. Shibata H, Haga H. Longevity. New Horizons in Aging Science. Tokyo: University of Tokyo Press; 1992. pp. 31–33. [Google Scholar]
  85. Shimokawa I, Higami Y, Tsuchiya T, Otani H, Komatsu T, Chiba T, Yamaza H. Life span extension by reduction of growth hormone-insulin like growth factor-1 axis: relation to calorie restriction. FASEB J. 2003;17:1108–1109. doi: 10.1096/fj.02-0819fje. [DOI] [PubMed] [Google Scholar]
  86. Simms HS, Berg BN. Longevity in relation to lesion onset. Geriatrics. 1962;17:235–242. [PubMed] [Google Scholar]
  87. Slama M, Susic D, Frohlich ED. Prevention of hypertension. Curr Opin Cardiol. 2002;17:531–536. doi: 10.1097/00001573-200209000-00014. [DOI] [PubMed] [Google Scholar]
  88. Sonntag WE, Lynch CD, Cefalu WT, Ingram RL, Bennett SA, Thornton PL, Khan AS. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF-1) on biological aging: inferences from moderate caloric-restricted animals. J Gerontol. 1999;54:B521–B538. doi: 10.1093/gerona/54.12.b521. [DOI] [PubMed] [Google Scholar]
  89. Sprott RL. Diet and calorie restriction. Exp Gerontol. 1997;32:205–214. doi: 10.1016/S0531-5565(96)00065-4. [DOI] [PubMed] [Google Scholar]
  90. Stamler J. The marked decline in coronary heart disease mortality rates in the United States 1968–1981: summary of findings and possible explanations. Cardiology. 1985;72:11–22. doi: 10.1159/000173836. [DOI] [PubMed] [Google Scholar]
  91. Stunkard AJ. Nutrition, aging and obesity. In: Rockstein M, Sussman ML, editors. Nutrition, Longevity and Aging. New York: Academic Press; 1976. pp. 253–284. [Google Scholar]
  92. Sytkowski PA, Kannel WB, D’Agostini RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med. 1990;322:1635–1641. doi: 10.1056/NEJM199006073222304. [DOI] [PubMed] [Google Scholar]
  93. Thurman JD, Bucci TJ, Hart RW, Turturro A. Survival, body weight, and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats. Toxicol Pathol. 1994;22:1–9. doi: 10.1177/019262339402200101. [DOI] [PubMed] [Google Scholar]
  94. Tjonneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewerts M, Melle L. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer. 2004;100:2326–2337. doi: 10.1002/cncr.20250. [DOI] [PubMed] [Google Scholar]
  95. Tuomiolehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Hanne-Parikka P, Keinanen-Kiukaanniemi S, Laakson M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350. doi: 10.1056/NEJM200105033441801. [DOI] [PubMed] [Google Scholar]
  96. Turturro A, Witt WW, Lewis S, Hass B, Lipman RD, Hart RW. Growth curves and survival characteristics of animals used in the Biomarker aging program. J Gerontol Biol Sci. 1999;54:B492–B501. doi: 10.1093/gerona/54.11.b492. [DOI] [PubMed] [Google Scholar]
  97. United Nations Statistical Yearbook 1955. New York: United Nations; 1957. pp. 51–55. [Google Scholar]
  98. Vallejo EA. La dieta de hombre a dias alternos in a la alimentacion de los viejos. Rev Clin Exp. 1957;63:25–49. [Google Scholar]
  99. Vaupel JW, Carey JR, Christensen K, Johnson TE, Yashin AI, Holm NV, Lachine IA, Kannisto V, Khazaeli AA, Liedo P, Longo VD, Zeng Y, Manton KG, Curtsinger JW. Biodemographic trajectories of longevity. Science. 1998;280:855–860. doi: 10.1126/science.280.5365.855. [DOI] [PubMed] [Google Scholar]
  100. Velthuis-te Wierik EJM, Berg H, Schaafsma G, Hendriks HFJ, Brouver A. Energy restriction, a useful intervention to retard human ageing? Results of a feasibility study. Eur J Clin Nutr. 1994;48:138–148. [PubMed] [Google Scholar]
  101. Wainwright C. Statins – is there no end to their usefulness? Cardiovasc Res. 2005;65:296–298. doi: 10.1016/j.cardiores.2004.11.030. [DOI] [PubMed] [Google Scholar]
  102. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80% BMJ. 2003;326:1419–1423. doi: 10.1136/bmj.326.7404.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Walford RL, Harris SB, Gunion MW. The calorically restricted low-fat, nutrient dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol and blood pressure in humans. Proc Natl Acad Sci USA. 1992;98:11533–11537. doi: 10.1073/pnas.89.23.11533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in Biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol Biol Sci. 2002;57A:B211–B224. doi: 10.1093/gerona/57.6.b211. [DOI] [PubMed] [Google Scholar]
  105. Walker J, Wynne H. The frequency and severity of adverse drug reactions in elderly people. Age Ageing. 1994;23:255–259. doi: 10.1093/ageing/23.3.255. [DOI] [PubMed] [Google Scholar]
  106. Wathen CN, Feig DS, Feightner JW, Abramson BL, Cheung AM. Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J. 2004;170:1535–1537. doi: 10.1503/cmaj.1030756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Weindruch R, Sohal RS. Caloric intake and aging. N Engl J Med. 1997;337:986–994. doi: 10.1056/NEJM199710023371407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Weindruch R, Walford RL. Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Charles C. Thomas; 1988. [Google Scholar]
  109. Weindruch R, Walford RL. Prospects for retarding human aging by dietary restriction. Chapter 6. In: Weindruch R, Walford RL, editors. Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Charles C. Thomas; 1988. pp. 295–337. [Google Scholar]
  110. Willcox B, Willcox C, Suzuki M. The Okinawa Way: How to Improve Your Health and Longevity Dramatically. London: Michael Joseph, Penguin; 2001. p. 29. [Google Scholar]
  111. Willett W, Manson JA, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76(Suppl):274S–280S. doi: 10.1093/ajcn/76/1.274S. [DOI] [PubMed] [Google Scholar]
  112. Wilmoth JR. Demography of longevity: past, present, and future trends. Exp Gerontol. 2000;35:1111–1229. doi: 10.1016/S0531-5565(00)00194-7. [DOI] [PubMed] [Google Scholar]
  113. The World Health Report 2003. Shaping the Future. Geneva, Switzerland: WHO; 2003. pp. 146–153. [Google Scholar]
  114. Yu BP, Masoro EJ, Murata I, Bertrand HA, Lynd FT. Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J Gerontol. 1982;37:130–141. doi: 10.1093/geronj/37.2.130. [DOI] [PubMed] [Google Scholar]

Articles from Age are provided here courtesy of American Aging Association

RESOURCES